A Study on Monitoring and Focussing of Adverse Drug Reactions Caused By Allopathic Medicines in a Tertiary Care Hospital

Authors

  • Firoz Khan* Department of Pharmacology, Subharti Medical College, Meerut, India Author
  • Saurabh Nimesh Department of Pharmacology, Subharti Medical College, Meerut, India Author
  • Tinku Kumar Department of Pharmacology, Subharti Medical College, Meerut, India Author

DOI:

https://doi.org/10.23880/apct-16000136

Keywords:

Adverse Drug Reaction, Causality Assessment, Antibiotics

Abstract

Adverse drug reaction is the major part of the all the medicines available just like two sides of the coin. On one side the medicines are most prestige for human health but if we focus on another side there are lots of side effects and misuse happens by this prestige drug. In a hospital there are some ADRs are reported but most of them are unreported due to not enough awareness of Pharmacovigilance Programme of India (PvPI). This programme helps to report every single individual including with doctors, nurses, pathologist, pharmacist, medical representative and other life sciences or non life sciences persons to report the adverse effect of the medication. In this case report the ADRs were monitored under the supervision of Subharti Medical College and Hospital, Meerut. All the happened ADR shall be treated under the supervision of professional doctors and reported. So, it was very tough to say, whose drug ready for produce adverse effect. Now, Adverse Drug Reactions are a global health problem and a leading cause of death, illness and injury in economically developed countries. The objective of this study was to identify the possible ways to improve the quality of the ADR reporting with a special focus on improving the aspect of ADR reporting that has to do with symptoms descriptions.

Downloads

Published

2018-08-27

Issue

Section

Articles

How to Cite

A Study on Monitoring and Focussing of Adverse Drug Reactions Caused By Allopathic Medicines in a Tertiary Care Hospital. (2018). Advances in Pharmacology & Clinical Trials, 3(3). https://doi.org/10.23880/apct-16000136

Most read articles by the same author(s)